Evidence map›Paper›PMID 17610893›Full record

ArticleJournal of molecular biology2007

Structural and functional analysis of two glutamate racemase isozymes from Bacillus anthracis and implications for inhibitor design.

Melissa May, Shahila Mehboob, Debbie C Mulhearn, Zhiqiang Wang, Huidong Yu, Gregory R J Thatcher, Bernard D Santarsiero, Michael E Johnson, Andrew D Mesecar

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Structure of dihydroorotase from Bacillus anthracis at 2.6 Å resolution.Acta crystallographica. Section F, Structural biology and crystallization communications · 2010
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Melissa MayCenter for Pharmaceutical Biotechnology, University of Illinois at Chicago, Chicago, IL 60607, USA.
Shahila Mehboob
Debbie C Mulhearn
Zhiqiang Wang
Huidong Yu
Gregory R J Thatcher
Bernard D Santarsiero
Michael E Johnson
Andrew D Mesecar
University of Illinois Chicago · US

Funding

X-RAY STUDY OF HORMONE-RECEPTOR AND PROTEIN-ANTIBODY COMPLEXESP41RR007707 · NCRR · UNIVERSITY OF CHICAGO · PI YANG, XIANGZHONG · 2002 to 2011
$17.3M
Novel Therapeutics for Bacillus anthracisU19AI056575 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI JOHNSON, MICHAEL E. · 2003 to 2007
$15.5M
Macromolecular X-ray Structure Facility InstrumentationS10RR017744 · NCRR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MESECAR, ANDREW D · 2003 to 2003
$346k
NCRR NIH HHS P41 RR007707NCRR NIH HHS S10 RR017744NIAID NIH HHS AI056575NIAID NIH HHS U19 AI056575
6 · The paper itself

Abstract

Glutamate racemase (RacE) is responsible for converting l-glutamate to d-glutamate, which is an essential component of peptidoglycan biosynthesis, and the primary constituent of the poly-gamma-d-glutamate capsule of the pathogen Bacillus anthracis. RacE enzymes are essential for bacterial growth and lack a human homolog, making them attractive targets for the design and development of antibacterial therapeutics. We have cloned, expressed and purified the two glutamate racemase isozymes, RacE1 and RacE2, from the B. anthracis genome. Through a series of steady-state kinetic studies, and based upon the ability of both RacE1 and RacE2 to catalyze the rapid formation of d-glutamate, we have determined that RacE1 and RacE2 are bona fide isozymes. The X-ray structures of B. anthracis RacE1 and RacE2, in complex with d-glutamate, were determined to resolutions of 1.75 A and 2.0 A. Both enzymes are dimers with monomers arranged in a "tail-to-tail" orientation, similar to the B. subtilis RacE structure, but differing substantially from the Aquifex pyrophilus RacE structure. The differences in quaternary structures produce differences in the active sites of racemases among the various species, which has important implications for structure-based, inhibitor design efforts within this class of enzymes. We found a Val to Ala variance at the entrance of the active site between RacE1 and RacE2, which results in the active site entrance being less sterically hindered for RacE1. Using a series of inhibitors, we show that this variance results in differences in the inhibitory activity against the two isozymes and suggest a strategy for structure-based inhibitor design to obtain broad-spectrum inhibitors for glutamate racemases.

Indexed as

Amino Acid IsomerasesAmino Acid SequenceAnti-Infective AgentsBacillus anthracisCloning, MolecularCrystallography, X-RayDrug DesignEnzyme InhibitorsGenome, BacterialKineticsMolecular Sequence DataProtein ConformationProtein IsoformsProtein Structure, QuaternarySequence Homology, Amino AcidAmino Acid IsomerasesAnti-Infective AgentsEnzyme Inhibitorsglutamate racemaseProtein Isoforms

Identifiers

PMID17610893
PMCPMC2736553
OpenAlexW2102548991

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.